Phospholipid-Protein Bioconjugates for Stable Autoantibody Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for autoimmune disorders, such as antiphospholipid syndrome, face challenges with low chemical stability, selectivity, and high costs due to the use of heterogeneous phospholipid molecules from natural sources, leading to time-consuming and unreliable tests.
Innovation Solution
Development of novel phospholipid-peptide and phospholipid-protein conjugates with improved stability and selectivity, utilizing a 1,2,3-triazole linker and biologically complementary molecules like beta2-GPI and prothrombin, which are covalently bound via CuAAC or SPAAC click chemistry, enhancing binding affinity and specificity for autoimmune antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If heterogeneous phospholipid molecules from natural sources are used in diagnostic tests, then the tests can detect autoimmune antibodies, but the chemical stability is low and selectivity is poor
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of phospholipids through synthetic analogues with defined stereochemistry and purity. This transforms the heterogeneous natural phospholipids into homogeneous synthetic versions with improved chemical stability while maintaining immunogenicity for antibody detection
Solution Approach 2:
The patent creates composite materials by conjugating phospholipids with carrier proteins (such as BSA, KLH, or lipoproteins) through stable linkers. This composite approach enhances the chemical stability and selectivity of the diagnostic reagents while enabling reliable detection of autoimmune antibodies
2Measurement precision
If heterogeneous phospholipid molecules from natural sources are used, then antibody detection is possible, but selectivity and sensitivity are low
Solution Approach 1:
The patent improves measurement precision by changing the purity and stereochemical definition parameters of phospholipid reagents. Synthetic phospholipid analogues with defined configurations provide superior selectivity for specific autoantibodies, reducing cross-reactivity and improving diagnostic accuracy
Solution Approach 2:
The patent applies local quality by introducing specific modifications at particular positions of the phospholipid molecule (such as fatty acid chain composition, head group variations, or conjugation sites). These localized changes enhance antibody-binding specificity while maintaining overall molecular functionality
3Reliability
If current diagnostic approaches with multiple separate tests are used, then comprehensive antibody detection is achieved, but time consumption and cost increase
Solution Approach 1:
The patent merges multiple separate diagnostic tests into a single integrated assay by using phospholipid-protein conjugates that can simultaneously detect multiple autoantibody types. This consolidation maintains comprehensive detection capability while reducing the number of separate tests required, thereby saving time and reducing costs
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel conjugates demonstrate high stability upon storage and specificity in detecting autoimmune antibodies, offering improved diagnostic performance and potential therapeutic applications for autoimmune diseases.
Implementation Method 1
phospholipid and protein are biologically complementary, i.e. interact in vivo
Data Source
Figure 1a~1b
Figure 2
Figure 3
AI summary
There is provided phospholipid-peptide or phospholipid-protein conjugates useful for identification of autoantibodies, and in particular autoantibodies directed towards phospholipids. There is further provided intermediates and methods for their preparation as well as synthesis of the phospholipid-peptide or phospholipid-protein conjugates.